Hematology
Robert Kyle, M.D.
Professor of Medicine, Laboratory Medicine and Pathology
Rochester, MN
Dr. Robert A. Kyle is a Professor of Medicine, Laboratory Medicine and Pathology at Mayo Clinic College of Medicine in Rochester, Minnesota. A pioneering figure in plasma cell disorder research, Dr. Kyle coined the term monoclonal gammopathy of undetermined significance (MGUS) and established its epidemiology and long-term prognosis. Over a career spanning more than six decades at Mayo Clinic, he has authored over 1,850 scientific papers and abstracts on myeloma and related disorders. He served
70+
Years in Practice
Credentials
Board Certifications
- Internal Medicine (ABIM)
- Hematology (ABIM)
Education & Training
- Medical School: Northwestern University Feinberg School of Medicine (1952)
- Residency: Mayo Clinic (Internal Medicine)
- Fellowship: Tufts University (Hematology)
- MS: University of Minnesota (1958)
Peer Recognition
- ASCO — David A. Karnofsky Award
2007
- ASH — Wallace Coulter Award
2008
Recognition & Leadership
Leadership Roles
- Former Chairman, Division of Hematology, Mayo Clinic
- Chairman, Scientific Advisory Board, International Myeloma Foundation
Clinical Focus
Subspecialties
Multiple Myeloma
Conditions & Treatments
Hematologic MalignanciesMultiple Myeloma
Practice Details
Hospital Affiliations
- Mayo Clinic - Rochester, MN
Experience
70+ years in practice